An emerging biotech company developing a first-to-market treatment for an ultra rare disease - known by very many names - reached out to Adnexi to:
Identify KOLs in the US and rest of world
We deployed the Adnexi platform to perform an algorithmic search for the disease of interest.
Adnexi provided the client with a complete solution, customized for this rare disease. We relied on Adnexi's proprietary search algorithm, to produce a complete and customized search.
Despite the rarity of this contidion, the Adnexi algorithmic search identified:
25,000 authors in the disease of interest
7,500 articles published on the disease
Our deliverables included:
Complete, searchable, ranked list that updates daily with new information
Navigate detail data on each KOL including contact information, affiliation history, publications, clinical trials, NIH grants, payment, NPI number and more.
A collaboration map for each KOL to enable the company to select advisory boards, publication groups and clinical trial investigators.
Our team at Adnexi would love to help you efficiently discover and map relevant KOLs for your disease of interest.